Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Par Pharmaceutical: The Winning Streak Continues (PRX)
Comtex Smartrend
Monday, October 4, 2010 - 11:52am
tags:
Par Pharmaceutical
Sanofi’s Hostile Bid Triggered by Genzyme CEO’s Selective Deafness
BNET Pharma
Monday, October 4, 2010 - 11:38am
tags:
Genzyme, Henri Termeer, hostile bid, M&A, Sanofi
Sanofi chief plots course for booming cancer, diabetes markets
Fierce Biotech
Monday, October 4, 2010 - 11:26am
tags:
Sanofi, Pharma CEOs, cancer, diabetes, Chris Viehbacher
Arena Pharmaceuticals Investors Smell A Rat
Pharmalot
Monday, October 4, 2010 - 11:24am
tags:
Arena Pharmaceuticals, investors, Lorqess, obesity, FDA, advisory panels
Novo Nordisk to Invest $73m in Expansion of U.S. Manufacturing Facility
Yahoo
Monday, October 4, 2010 - 11:23am
tags:
Novo Nordisk, drug manufacturing
Genzyme advises shareholders not to act on bid
Marketwatch
Monday, October 4, 2010 - 11:22am
tags:
Genzyme, M&A, Sanofi, shareholders, hostile bid
Small study affirms Avastin as AMD treatment
Fierce Pharma
Monday, October 4, 2010 - 10:15am
tags:
Avastin, age-related macular degeneration, Roche, Lucentis, Genentech
Pfizer's Osteoarthritis Drug Runs Into Unique Roadblock
Seeking Alpha
Monday, October 4, 2010 - 10:14am
tags:
Pfizer, osteoarthritis, tanezumab
Teva Drug Approval Delayed
Yahoo/Zacks.com
Monday, October 4, 2010 - 10:11am
tags:
Teva Pharmaceuticals, Neutroval, biologics, BLA, FDA, febrile neutropenia
Endo's Latest Acquisition Builds Out Pain Franchise, Generics Lineup
Seeking Alpha
Monday, October 4, 2010 - 10:08am
tags:
generics, Endo, Qualitest, M&A, painkillers
Sanofi Likely to Shell out More for Genzyme: Analysts
CNBC
Monday, October 4, 2010 - 10:07am
tags:
analysts, Sanofi, M&A, hostile takeover, Genzyme
Drug stocks sluggish in early action
Marketwatch
Monday, October 4, 2010 - 10:03am
tags:
drug stocks
Read Sanofi’s $18.5 Billion Hostile Offer for Genzyme
WSJ Online
Monday, October 4, 2010 - 10:02am
tags:
hostile takeover, M&A, Sanofi, Genzyme
Antipsychotics, Illegal Marketing And Lawsuits
NY Times, NY
Monday, October 4, 2010 - 10:00am
tags:
lawsuits, antipsychotics, JNJ, AstraZeneca, Eli Lilly, Pfizer, Bristol-Myers Squibb
Johnson & Johnson: Strong Company At an Attractive Price, Part 2
Seeking Alpha
Monday, October 4, 2010 - 9:58am
tags:
JNJ
Johnson & Johnson: A Strong Company at an Attractive Price, Part 1
Seeking Alpha
Monday, October 4, 2010 - 9:57am
tags:
JNJ
Sanofi launches $18.5 bln hostile bid for Genzyme
Marketwatch
Monday, October 4, 2010 - 9:56am
tags:
M&A, Genzyme, Sanofi
Here We Go Again: Novartis Fined for Off-Label Marketing
Seeking Alpha
Sunday, October 3, 2010 - 12:22pm
tags:
Novartis, off label
Glaxo Meets Big Disappointment in Failed Herpes Vaccine
Seeking Alpha
Sunday, October 3, 2010 - 12:22pm
tags:
GSK, herpes simplex vaccine
Teva launches prostate cancer Phase III study
Globes, Israel
Sunday, October 3, 2010 - 12:18pm
tags:
Teva Pharmaceuticals, OncoGenex, prostate cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.